LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,... The post Glancy Prongay...
A new study published in the “ACS Pharmacology & Translational Science” journal has revealed that psychedelics such as psilocybin may combat stress...
The global inflation surge and monetary policy tightening by major central banks have all contributed to the market volatility this year. Despite that,...
Condensed Interim Consolidated Financial Statements For The Three and Nine Months Ended July 31, 2023 (Expressed in United States Dollars) (Unaudited)...
Silo's SPC-15 was developed in collaboration with Columbia University The post Silo Pharma to test a novel experimental intranasal formulation for PTSD...
MindMed has completed dosing of its main Phase 2b clinical trial. The study — investigating LSD for Generalized Anxiety Disorder (GAD) — has dosed...
As the digital era transforms, fifth-generation (5G) wireless technology emerges as the linchpin of tomorrow’s connectivity. That represents a colossal...
Investing in biotech stocks is not for the meek. Losses can be very large and occur very quickly. In fact, I’ve uncovered seven of the top...
Local markets are enjoying a gentle uplift this morning, while med-tech EMD builds a warchest to fight PTSD with MDMA. ... Read More The post ASX...
The recent choppiness in the electric vehicle (EV) sector may give a fleeting sense of pause, but weakness often paves the path to opportunity. As global...